Artery Research

Volume 24, Issue C, December 2018, Pages 68 - 68

P68 THE HIDDEN PREDICTOR OF CARDIOVASCULAR OUTCOME

Authors
José Sousa, João Lopes, Liliana Reis, Marta Madeira, Carolina Lourenço, Lino Gonçalves
Hospital Geral, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
Available Online 4 December 2018.
DOI
10.1016/j.artres.2018.10.121How to use a DOI?
Abstract

Background: Hyperuricemia is common in patients with hypertension, diabetes and obesity. Whether it is an independent cardiovascular risk factor (CVRF) or not remains controversial.

Purpose: To determine the prognostic value of uricemia in the setting of acute coronary syndrome (ACS).

Methods: Retrospective single-center study comprising 1187 patients consecutively admitted into a cardiac intensive care unit for ACS, in whom uricemia was measured during hospitalization. Follow-up targeted all-cause mortality (FUM), reinfarction, percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG) and acute heart failure (AHF). Statistical analysis was performed using SPSS, version 25.

Results: Mean age was 68.0 ± 13.3y and 30.4% were female. Prevalence of CVRF was as follows: hypertension, 76.9%; diabetes, 33.4%; dyslipidemia, 65.6%; smoking, 35.5%; chronic kidney disease (CKD), 20.5%. Uricemia was 377 ± 119.2 μmol/l, whereas body mass index (BMI) was 27.8 ± 4.4 kg/m2. In-hospital mortality (IHM) was 6%, while median follow-up time was 6y, encompassing the following event rates: FUM, 36.9%; reinfarction, 19.4%; PCI, 21.1%; CABG, 2.3%; AHF, 16.6%. Uricemia was higher in males (p = 0.001) and in patients with hypertension (p < 0.001), diabetes mellitus (p = 0.009) and CKD (p < 0.001) and lower in patients with dyslipidemia (p = 0.031) and smokers (p = 0.03). Age and BMI displayed weak correlation with uricemia. Hyperuricemia had no effect on the burden of reinfaction, PCI and CABG. In a model of logistic regression including the above-mentioned CVRF, hyperuricemia was an independent predictor of IHM (p = 0.009, Hosmer-Lemeshow p = 0.685), FUM (p < 0.001, Hosmer-Lemeshow p = 0.056) and AHF (p = 0.001, Hosmer-Lemeshow p = 0.367).

Conclusion: Hyperuricemia is an independent predictor of mortality and AHF in the setting of ACS.

Open Access
This is an open access article distributed under the CC BY-NC license.

References

1.JA Singh, When gout goes to the heart: does gout equal a cardiovascular disease risk factor?, Ann Rheum Dis., Vol. 74, No. 4, Apr 2015, pp. 631-4.
2.H Skak-Nielsen, C Torp-Pedersen, N Finer, ID Caterson, L Van Gaal, WP James, AP Maggioni, AM Sharma, W Coutinho, and C Andersson, Uric acid as a risk factor for cardiovascular disease and mortality in overweight/obese individuals, PLoS One, Vol. 8, No. 3, 2013. e59121.
3.L Qin, Z Yang, H Gu, S Lu, Q Shi, Y Xing, X Li, R Li, G Ning, and Q Su, Association between serum uric acid levels and cardiovascular disease in middle-aged and elderly Chinese individuals, BMC Cardiovasc Disord, Vol. 14, 25 Feb 2014, pp. 26. https://doi.org/10.1186/1471-2261-14-26.
Journal
Artery Research
Volume-Issue
24 - C
Pages
68 - 68
Publication Date
2018/12/04
ISSN (Online)
1876-4401
ISSN (Print)
1872-9312
DOI
10.1016/j.artres.2018.10.121How to use a DOI?
Open Access
This is an open access article distributed under the CC BY-NC license.

Cite this article

TY  - JOUR
AU  - José Sousa
AU  - João Lopes
AU  - Liliana Reis
AU  - Marta Madeira
AU  - Carolina Lourenço
AU  - Lino Gonçalves
PY  - 2018
DA  - 2018/12/04
TI  - P68 THE HIDDEN PREDICTOR OF CARDIOVASCULAR OUTCOME
JO  - Artery Research
SP  - 68
EP  - 68
VL  - 24
IS  - C
SN  - 1876-4401
UR  - https://doi.org/10.1016/j.artres.2018.10.121
DO  - 10.1016/j.artres.2018.10.121
ID  - Sousa2018
ER  -